Page 13 - Serum Institute Of India

Serum prices Covishield at Rs 400 for Centre, Rs 600 for private hospitals

These are the prices for institutional sales, and not the maximum retail price, which will be announced later.

Covid vaccine, price and availability after May 1: All you need to know

In this podcast, we take a look at all those important updates related to coronavirus vaccine in a quick time

States to get Covishield vaccine at Rs 400, pvt hospitals at Rs 600 a dose

Serum said its vaccine, which it manufactures as a partner of Britain's AstraZeneca, is "affordable to any other" in the world

Serum institute to sell Covishield to private hospitals at Rs 600 per dose

The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees per dose and to private hospitals at Rs 600 rupees

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

A new vaccine regime

Govt conducts welcome course correction

Govt acting with sensitivity, speed to meet increased oxygen demand: Modi

He also said the government has now allowed vaccination for every adult starting May 1

Govt to provide Rs 4,500 cr to vaccine manufacturers to ramp up capacity

Looking to ramp up supplies ahead of the opening of Covid vaccination to all citizens over 18 years of age, the government has approved a payment of about Rs 4,500 crore as advance to vaccine makers

India hopeful US will soon end curbs on Covid vaccine raw materials export

The White House has invoked the wartime powers of the Defense Production Act to preserve vaccine raw materials for its own companies

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

Expanding vaccine supply

Some good moves but freer pricing needed

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

SII CEO urges US to lift raw material export ban to up vaccine production

Adar Poonawalla on Friday said the US needs to lift its embargo on raw material exports

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Covid-19 vaccine Sputnik V gets DCGI nod; may be available by May

Russian Covid-19 vaccine granted restricted emergency-use authorisation in India

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

Centre says problem is not of Covid vaccine shortage but of planning

'On one hand, we have states like Kerala where there is zero wastage (of vaccine) and on the other hand, we have several other states where there still is 8-9% of wastage,' says Union Health Secretary